Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Iavarone

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Alimentary Pharmacology & Therapeutics|June 20, 2018
Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for hepatitis BA Loglio, M Iavarone, G Grossi, et al.
Scientific Reports|December 10, 2016
Observation of superconducting vortex clusters in S/F hybridsC Di Giorgio, F Bobba, A M Cucolo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 26, 2008
Transarterial embolization with microspheres in the treatment of monofocal HCCA Nicolini, P Fasani, M A Manini, et al.
Scientific Reports|May 2, 2018
Evolution of Metastable Defects and Its Effect on the Electronic Properties of MoS<sub>2</sub> FilmsM Precner, T Polaković, Qiao Qiao, et al.
ESMO Open|March 6, 2025
Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab-bevacizumab resistance and worse survival in advanced hepatocarcinomaL Gramantieri, A Montagner, A Arleo, et al.
Physical Review Letters|October 26, 2002
Two-band superconductivity in MgB2M Iavarone, G Karapetrov, A E Koshelev, et al.
Nature Communications|February 18, 2015
Emergence of coherence in the charge-density wave state of 2H-NbSe2U Chatterjee, J Zhao, M Iavarone, et al.
ESMO Open|January 28, 2025
Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trialF Piscaglia, G Masi, E Martinelli, et al.
ESMO Open|November 30, 2021
Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinibM Rimini, M Kudo, T Tada, et al.
ESMO Open|October 8, 2022
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysisM Rimini, L Rimassa, K Ueshima, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Alimentary Pharmacology & Therapeutics|June 20, 2018
Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for hepatitis BA Loglio, M Iavarone, G Grossi, et al.
Scientific Reports|December 10, 2016
Observation of superconducting vortex clusters in S/F hybridsC Di Giorgio, F Bobba, A M Cucolo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 26, 2008
Transarterial embolization with microspheres in the treatment of monofocal HCCA Nicolini, P Fasani, M A Manini, et al.
Scientific Reports|May 2, 2018
Evolution of Metastable Defects and Its Effect on the Electronic Properties of MoS<sub>2</sub> FilmsM Precner, T Polaković, Qiao Qiao, et al.
ESMO Open|March 6, 2025
Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab-bevacizumab resistance and worse survival in advanced hepatocarcinomaL Gramantieri, A Montagner, A Arleo, et al.
Physical Review Letters|October 26, 2002
Two-band superconductivity in MgB2M Iavarone, G Karapetrov, A E Koshelev, et al.
Nature Communications|February 18, 2015
Emergence of coherence in the charge-density wave state of 2H-NbSe2U Chatterjee, J Zhao, M Iavarone, et al.
ESMO Open|January 28, 2025
Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trialF Piscaglia, G Masi, E Martinelli, et al.
ESMO Open|November 30, 2021
Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinibM Rimini, M Kudo, T Tada, et al.
ESMO Open|October 8, 2022
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysisM Rimini, L Rimassa, K Ueshima, et al.
Pageof 2